1-7 of 7
Keywords: Desogestrel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short- and Long-Term Effects on Lipid Metabolism of Oral Contraceptives Containing 30 µg Ethinylestradiol and 150 µg Desogestrel or 3-Keto-Desogestrel

Subject Area:
Endocrinology
H. Kuhl, C. Jung-Hoffmann, M. Fitzner, W. März, W. Gross
Journal: Hormone Research in Paediatrics
Hormone Research (1995) 44 (3): 121–125.
https://doi.org/10.1159/000184610
Published Online: 05 December 2008
...H. Kuhl; C. Jung-Hoffmann; M. Fitzner; W. März; W. Gross During a cross-over study with young female volunteers, the effects of a combination of 30 µg ethinylestradiol (EE) and 150 µg desogestrel (DG) or 3-keto-desogestrel (KDG) upon lipid metabolism were investigated on day 3 of the first cycle...
View article titled, Short- and Long-Term Effects on Lipid Metabolism of Oral Contraceptives Containing 30 µg Ethinylestradiol and 150 µg <span class="search-highlight">Desogestrel</span> or 3-Keto-<span class="search-highlight">Desogestrel</span>
Open the PDF for Short- and Long-Term Effects on Lipid Metabolism of Oral Contraceptives Containing 30 µg Ethinylestradiol and 150 µg <span class="search-highlight">Desogestrel</span> or 3-Keto-<span class="search-highlight">Desogestrel</span> in another window
Journal Articles

Prodrug versus Drug Effects of 150 μg Desogestrel or 3-Keto-Desogestrel in Combination with 30 μg Ethinylestradiol on Hormonal Parameters: Relevance of the Peak Serum Level of 3-Keto-Desogestrel

Subject Area:
Endocrinology , Women's and Children's Health
H. Kuhl, C. Jung-Hoffmann, M. Fitzner
Journal: Hormone Research in Paediatrics
Hormone Research (1995) 44 (3): 126–132.
https://doi.org/10.1159/000184612
Published Online: 05 December 2008
...H. Kuhl; C. Jung-Hoffmann; M. Fitzner The pharmacokinetics and pharmacodynamics of 150 μg desogestrel (DG) or 150 μg 3-keto-desogestrel (KDG) in combination with 30 μg ethinylestradiol (EE) were compared in a cross-over study. While the EE levels as well as the area under the curve (AUC) of KDG did...
View article titled, Prodrug versus Drug Effects of 150 μg <span class="search-highlight">Desogestrel</span> or 3-Keto-<span class="search-highlight">Desogestrel</span> in Combination with 30 μg Ethinylestradiol on Hormonal Parameters: Relevance of the Peak Serum Level of 3-Keto-<span class="search-highlight">Desogestrel</span>
Open the PDF for Prodrug versus Drug Effects of 150 μg <span class="search-highlight">Desogestrel</span> or 3-Keto-<span class="search-highlight">Desogestrel</span> in Combination with 30 μg Ethinylestradiol on Hormonal Parameters: Relevance of the Peak Serum Level of 3-Keto-<span class="search-highlight">Desogestrel</span> in another window
Journal Articles

Serum Concentrations of Ethinylestradiol, 3-Keto-Desogestrel, SHBG, CBG and Gonadotropins during Treatment with a Biphasic Oral Contraceptive Containing Desogestrel

Subject Area:
Endocrinology , Women's and Children's Health
C. Jung-Hoffmann, A. Storch, H. Kuhl
Journal: Hormone Research in Paediatrics
Hormone Research (1992) 38 (3-4): 184–189.
https://doi.org/10.1159/000182537
Published Online: 03 December 2008
...C. Jung-Hoffmann; A. Storch; H. Kuhl During a cross-over study, the pharmacokinetics of ethinylestradiol (EE) and 3-keto-desogestrel (KDG) were investigated on days 7 and 22 of one cycle of treatment with two biphasic formulations containing 50 µg EE (7 tablets) and 50 µg EE + 125 µg desogestrel...
View article titled, Serum Concentrations of Ethinylestradiol, 3-Keto-<span class="search-highlight">Desogestrel</span>, SHBG, CBG and Gonadotropins during Treatment with a Biphasic Oral Contraceptive Containing <span class="search-highlight">Desogestrel</span>
Open the PDF for Serum Concentrations of Ethinylestradiol, 3-Keto-<span class="search-highlight">Desogestrel</span>, SHBG, CBG and Gonadotropins during Treatment with a Biphasic Oral Contraceptive Containing <span class="search-highlight">Desogestrel</span> in another window
Journal Articles

Concentration of Ethinyl Estradiol in the Serum of 31 Young Women following a Treatment Period of 3 Months with Two Low-Dose Oral Contraceptives in an Intraindividual Cross-Over Design

Subject Area:
Endocrinology , Women's and Children's Health
W. Kuhnz, D. Back, J. Power, B. Schütt, T. Louton
Journal: Hormone Research in Paediatrics
Hormone Research (1991) 36 (1-2): 63–69.
https://doi.org/10.1159/000182110
Published Online: 02 December 2008
...W. Kuhnz; D. Back; J. Power; B. Schütt; T. Louton Two low-dose oral contraceptives, both containing the same dose of ethinyl estradiol (EE 2 ) but different progestins (gestodene and desogestrel, respectively), were compared with respect to the relative bioavailability of EE 2 . The study...
View article titled, Concentration of Ethinyl Estradiol in the Serum of 31 Young Women following a Treatment Period of 3 Months with Two Low-Dose Oral Contraceptives in an Intraindividual Cross-Over Design
Open the PDF for Concentration of Ethinyl Estradiol in the Serum of 31 Young Women following a Treatment Period of 3 Months with Two Low-Dose Oral Contraceptives in an Intraindividual Cross-Over Design in another window
Journal Articles

Comparison of Serum Ethinyl Estradiol, Sex-Hormone-Binding Globulin, Corticoid-Binding Globulin and Cortisol Levels in Women Using Two Low-Dose Combined Oral Contraceptives

Subject Area:
Endocrinology , Women's and Children's Health
M. Hümpel, U. Täuber, W. Kuhnz, M. Pfeffer, K. Brill, R. Heithecker, T. Louton, B. Steinberg
Journal: Hormone Research in Paediatrics
Hormone Research (1990) 33 (1): 35–39.
https://doi.org/10.1159/000181445
Published Online: 02 December 2008
...M. Hümpel; U. Täuber; W. Kuhnz; M. Pfeffer; K. Brill; R. Heithecker; T. Louton; B. Steinberg The study included 69 women taking a desogestrel (n = 30)- or gestodene (n = 39)-containing low-dose combined oral contraceptive for at least 3 months. Group size was calculated to detect a difference...
View article titled, Comparison of Serum Ethinyl Estradiol, Sex-Hormone-Binding Globulin, Corticoid-Binding Globulin and Cortisol Levels in Women Using Two Low-Dose Combined Oral Contraceptives
Open the PDF for Comparison of Serum Ethinyl Estradiol, Sex-Hormone-Binding Globulin, Corticoid-Binding Globulin and Cortisol Levels in Women Using Two Low-Dose Combined Oral Contraceptives in another window
Journal Articles

Relative Bioavailability of Ethinyl Estradiol from Two Different Oral Contraceptive Formulations after Single Oral Administration to 18 Women in an Intraindividual Cross-Over Design

Subject Area:
Endocrinology , Women's and Children's Health
W. Kuhnz, M. Hümpel, B. Schütt, T. Louton, B. Steinberg, C. Gansau
Journal: Hormone Research in Paediatrics
Hormone Research (1990) 33 (1): 40–44.
https://doi.org/10.1159/000181446
Published Online: 02 December 2008
...W. Kuhnz; M. Hümpel; B. Schütt; T. Louton; B. Steinberg; C. Gansau Two low-dose oral contraceptives, both containing the same dose of ethinyl estradiol (EE 2 ) but different progestins (gestodene and desogestrel, respectively), were compared with respect to the relative bioavailability of EE 2...
View article titled, Relative Bioavailability of Ethinyl Estradiol from Two Different Oral Contraceptive Formulations after Single Oral Administration to 18 Women in an Intraindividual Cross-Over Design
Open the PDF for Relative Bioavailability of Ethinyl Estradiol from Two Different Oral Contraceptive Formulations after Single Oral Administration to 18 Women in an Intraindividual Cross-Over Design in another window
Journal Articles

Oral Contraceptives Containing 20 or 30 μg Ethinylestradiol and 150 μg Desogestrel: Pharmacokinetics and Pharmacodynamic Parameters

Subject Area:
Endocrinology , Women's and Children's Health
C. Jung-Hoffmann, M. Fitzner, H. Kuhl
Journal: Hormone Research in Paediatrics
Hormone Research (1991) 36 (5-6): 238–246.
https://doi.org/10.1159/000182172
Published Online: 02 December 2008
...C. Jung-Hoffmann; M. Fitzner; H. Kuhl The serum concentrations of ethinylestradiol (EE) and 3-keto-desogestrel (KDG) were compared during treatment with a combination of 20 µg EE + 150 µg DG (20EE/DG) or of 30 µg EE + 150 µg DG (30EE/DG). During intake of both preparations, the peak levels...
View article titled, Oral Contraceptives Containing 20 or 30 μg Ethinylestradiol and 150 μg <span class="search-highlight">Desogestrel</span>: Pharmacokinetics and Pharmacodynamic Parameters
Open the PDF for Oral Contraceptives Containing 20 or 30 μg Ethinylestradiol and 150 μg <span class="search-highlight">Desogestrel</span>: Pharmacokinetics and Pharmacodynamic Parameters in another window